Not all sufferers with CLL require therapy. Even with all the latest improvements, the iwCLL even now recommends watchful observation for clients with asymptomatic sickness.86 This recommendation is based on no less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Pemain baru https://randallk652qzh1.blogpixi.com/profile